Treatment with TPA

Introduction:

Stroke - also referred to as "brain attack" - is the third leading cause of death in the United States after heart disease and cancer. It is the leading cause of serious long term adult disability in the U.S.

In the past, the main treatment of stroke is prevention. After stroke the main treatment is supportive care, minimize complications and prepare patient for stroke rehabilitation.

ActivaseŽ (Tissue Plasminogen Activator), better known as TPA has been used for treatment of acute heart attack for several years now. Its benefit in reducing the damage from heart attack is clearly established.

It has now clearly shown that TPA can help to reduce the long term disability from a stroke as well.

Stroke is slightly more complicated than a heart attack for several reasons:

Quick questions to establish whether patient has a stroke

Importance of establishing time of onset of stroke

It is very important to establish the time of onset of stroke. If the time of onset cannot be reasonably established, patient is not a candidate for TPA.

Questions for patient/family about symptom onset time

TPA inclusion criteria
Anticoagulant to prevent stroke
Stroke information center

 arrow_up.gif (1348 bytes)